Skip to main content

AIX Ventures — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

75
Companies
$1.7B
Total invested
$21.3M
Avg. check
36
Industries
Artificial Intelligence (AI) 17Biotechnology 9Software 7Health Care 6Machine Learning 3Therapeutics 3+30 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 75
Unreasonable Labs
September 2025

Unreasonable Labs is an artificial intelligence research and technology company that develops AI systems.

Palo Alto$13.5M Seed
Curated For You
September 2025

Curated For You is an e-Commerce platform that offers customer intelligence for online businesses.

Consumer Goods · Houston$8.3M Seed
Atomic AI
August 2023

Atomic AI combines machine learning with structural biology to enable the design of RNA-targeted small molecules and RNA-based therapeutics.

Artificial Intelligence (AI) · South San FranciscoSeries A
Therna Biosciences
August 2025

Therna Biosciences is a medicines development company that specializes in designing RNA therapeutics programme.

Biotechnology · San Francisco$10.0M Seed
Ubenwa Health
July 2022

Ubenwa Health is a Montréal-based MedTech startup building the future of automated sound-based medical diagnostics.

Artificial Intelligence (AI) · Montréal$2.5M Pre-Seed
Illoca
May 2026

Illoca is building a platform that leverages generative AI to accelerate commercial architecture workflows.

Artificial Intelligence (AI) · San Francisco$13.0M Seed
Exazyme
May 2023

Exazyme leverages advanced AI/ML tools to streamline protein design in the most efficient and effective way.

Artificial Intelligence (AI) · Berlin$2.2M Seed
chromie Health
May 2026

Chromie Health uses AI to streamline healthcare scheduling and improve team workflows.

Artificial Intelligence (AI) · New York$2.0M Pre-Seed
BranchLab
May 2026

The AI Platform for Pharma Commercialization

Artificial Intelligence (AI) · New York$28.8M Series A
HoneyHive
April 2025

HoneyHive Cloud is an enterprise platform purpose-built for testing, debugging, and monitoring LLM apps.

Artificial Intelligence (AI) · New York$5.5M Seed
Bloom AI
March 2026

Bloom is a SaaS solution for e-commerce merchants looking to maximize ROI on product photos.

E-Commerce · New York$3.7M Series Unknown
ALIGNMT AI
August 2025

ALIGNMT AI is a software company that offers a comprehensive AI governance and risk management platform for healthcare organizations.

Health Care · New York$6.5M Seed
Tahoe Therapeutics
August 2025

Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.

Artificial Intelligence (AI) · South San Francisco$30.0M Venture - Series Unknown
Coverflow
July 2025

Coverflow is an AI-driven platform for automating insurance processes like policy checking and AMS updates.

Artificial Intelligence (AI) · San Francisco$4.8M Seed
Ryght AI
June 2025

Ryght AI develops an enterprise-scale generative AI platform and applications to accelerate clinical trials.

Artificial Intelligence (AI) · Laguna Beach$3.0M Seed
Parallel Bio
June 2025

Parallel Bio develops tools that help in the discovery and development of immunotherapies.

Biotechnology · Watertown$21.0M Series A
Laurel
June 2025

Laurel automates timesheet management for legal and accounting firms using AI.

Artificial Intelligence (AI) · San Francisco$80.0M Series C
Alphabiome.ai
May 2025

AI-Powered Microbiome Intelligence for Human Health

Artificial Intelligence (AI) · Tel Aviv$8.0M Seed
Stately Bio
May 2025

Stately Bio is the trade-off between measuring cells and keeping them alive.

Biotechnology · Chicago$12.0M Seed
Ataraxis
March 2025

Ataraxis is an AI-based diagnostic platform that helps develop personalized treatment plans.

Artificial Intelligence (AI) · New York$20.4M Series A
Workhelix
February 2025

Workhelix is a developer of workforce management platform to assist with business management.

Artificial Intelligence (AI) · Palo Alto$15.0M Series A
Ignota Labs
February 2025

Ignota Labs recognizes that safety errors during the drug discovery process.

Artificial Intelligence (AI) · London$6.9M Seed
TollBit
October 2024

TollBit is a content monetization platform that allows AI bots and data scrapers to pay for content instead of scraping data from websites.

Artificial Intelligence (AI) · New York$24.0M Series A
Ideogram
February 2024

Ideogram is an artificial intelligence startup that provides generative text-to-image technology.

Artificial Intelligence (AI) · Toronto$80.0M Series A

Where AIX Ventures invests

Artificial Intelligence (AI)17
Biotechnology9
Software7
Health Care6
Machine Learning3
Therapeutics3

About AIX Ventures's portfolio

How many companies has AIX Ventures invested in?

AIX Ventures has invested in 75 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does AIX Ventures invest in?

AIX Ventures's top investment sectors include Artificial Intelligence (AI), Biotechnology, Software, Health Care, Machine Learning. The firm invests across 36 different industry categories.

What is AIX Ventures's largest investment?

Among tracked funding rounds, Laurel received $80.0M in a Series C round. AIX Ventures's total known invested capital is $1.7B.

What is the average investment size for AIX Ventures?

AIX Ventures's average investment size is $21.3M across its portfolio of 75 companies.

What are AIX Ventures's most recent investments?

Recent AIX Ventures portfolio additions include Unreasonable Labs, Curated For You, Atomic AI, Therna Biosciences, Ubenwa Health. These companies were founded in 2020 or later.

Reach the founders behind these 75 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →